223 related articles for article (PubMed ID: 22069543)
1. Protein Domain Analysis of C. botulinum Type A Neurotoxin and Its Relationship with Other Botulinum Serotypes.
Sharma SK; Basavanna U; Shukla HD
Toxins (Basel); 2010 Jan; 2(1):1-9. PubMed ID: 22069543
[TBL] [Abstract][Full Text] [Related]
2. Differential endopeptidase activity of different forms of type A botulinum neurotoxin: A unique relationship between the size of the substrate and activity of the enzyme.
Ambrin G; Kumar R; Singh BR
Toxicon; 2018 Mar; 144():34-41. PubMed ID: 29309744
[TBL] [Abstract][Full Text] [Related]
3. Association of botulinum neurotoxin serotype A light chain with plasma membrane-bound SNAP-25.
Chen S; Barbieri JT
J Biol Chem; 2011 Apr; 286(17):15067-72. PubMed ID: 21378164
[TBL] [Abstract][Full Text] [Related]
4. Functional characterization of botulinum neurotoxin serotype H as a hybrid of known serotypes F and A (BoNT F/A).
Kalb SR; Baudys J; Raphael BH; Dykes JK; Lúquez C; Maslanka SE; Barr JR
Anal Chem; 2015 Apr; 87(7):3911-7. PubMed ID: 25731972
[TBL] [Abstract][Full Text] [Related]
5. Uptake of botulinum neurotoxin into cultured neurons.
Keller JE; Cai F; Neale EA
Biochemistry; 2004 Jan; 43(2):526-32. PubMed ID: 14717608
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis of activation of endopeptidase activity of botulinum neurotoxin type E.
Kukreja RV; Sharma SK; Singh BR
Biochemistry; 2010 Mar; 49(11):2510-9. PubMed ID: 20178376
[TBL] [Abstract][Full Text] [Related]
7. Structure of botulinum neurotoxin type D light chain at 1.65 A resolution: repercussions for VAMP-2 substrate specificity.
Arndt JW; Chai Q; Christian T; Stevens RC
Biochemistry; 2006 Mar; 45(10):3255-62. PubMed ID: 16519520
[TBL] [Abstract][Full Text] [Related]
8. Proteolysis of SNAP-25 isoforms by botulinum neurotoxin types A, C, and E: domains and amino acid residues controlling the formation of enzyme-substrate complexes and cleavage.
Vaidyanathan VV; Yoshino K; Jahnz M; Dörries C; Bade S; Nauenburg S; Niemann H; Binz T
J Neurochem; 1999 Jan; 72(1):327-37. PubMed ID: 9886085
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of the endopeptidase activity of purified botulinum neurotoxins A and E by an isolated component of the native neurotoxin associated proteins.
Sharma SK; Singh BR
Biochemistry; 2004 Apr; 43(16):4791-8. PubMed ID: 15096048
[TBL] [Abstract][Full Text] [Related]
10. A substrate sensor chip to assay the enzymatic activity of Botulinum neurotoxin A.
Lévêque C; Ferracci G; Maulet Y; Grand-Masson C; Blanchard MP; Seagar M; El Far O
Biosens Bioelectron; 2013 Nov; 49():276-81. PubMed ID: 23787358
[TBL] [Abstract][Full Text] [Related]
11. Unique substrate recognition by botulinum neurotoxins serotypes A and E.
Chen S; Barbieri JT
J Biol Chem; 2006 Apr; 281(16):10906-11. PubMed ID: 16478727
[TBL] [Abstract][Full Text] [Related]
12. Association of botulinum neurotoxin serotypes a and B with synaptic vesicle protein complexes.
Baldwin MR; Barbieri JT
Biochemistry; 2007 Mar; 46(11):3200-10. PubMed ID: 17311420
[TBL] [Abstract][Full Text] [Related]
13. A Comprehensive Structural Analysis of
Gregory KS; Acharya KR
Toxins (Basel); 2023 Jan; 15(2):. PubMed ID: 36828407
[TBL] [Abstract][Full Text] [Related]
14. Complete DNA sequences of the botulinum neurotoxin complex of Clostridium botulinum type A-Hall (Allergan) strain.
Zhang L; Lin WJ; Li S; Aoki KR
Gene; 2003 Oct; 315():21-32. PubMed ID: 14557061
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of substrate recognition by botulinum neurotoxin serotype A.
Chen S; Kim JP; Barbieri JT
J Biol Chem; 2007 Mar; 282(13):9621-9627. PubMed ID: 17244603
[TBL] [Abstract][Full Text] [Related]
16. Recombination and insertion events involving the botulinum neurotoxin complex genes in Clostridium botulinum types A, B, E and F and Clostridium butyricum type E strains.
Hill KK; Xie G; Foley BT; Smith TJ; Munk AC; Bruce D; Smith LA; Brettin TS; Detter JC
BMC Biol; 2009 Oct; 7():66. PubMed ID: 19804621
[TBL] [Abstract][Full Text] [Related]
17. Use of a recombinant fluorescent substrate with cleavage sites for all botulinum neurotoxins in high-throughput screening of natural product extracts for inhibitors of serotypes A, B, and E.
Hines HB; Kim AD; Stafford RG; Badie SS; Brueggeman EE; Newman DJ; Schmidt JJ
Appl Environ Microbiol; 2008 Feb; 74(3):653-9. PubMed ID: 18083881
[TBL] [Abstract][Full Text] [Related]
18. Genetic diversity within Clostridium botulinum serotypes, botulinum neurotoxin gene clusters and toxin subtypes.
Hill KK; Smith TJ
Curr Top Microbiol Immunol; 2013; 364():1-20. PubMed ID: 23239346
[TBL] [Abstract][Full Text] [Related]
19. [Clostridium botulinum and botulinum neurotoxin].
Hirai Y
Brain Nerve; 2011 Jul; 63(7):755-61. PubMed ID: 21747146
[TBL] [Abstract][Full Text] [Related]
20. Optimization of SNAP-25 and VAMP-2 Cleavage by Botulinum Neurotoxin Serotypes A-F Employing Taguchi Design-of-Experiments.
von Berg L; Stern D; Weisemann J; Rummel A; Dorner MB; Dorner BG
Toxins (Basel); 2019 Oct; 11(10):. PubMed ID: 31614566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
